HAEMOPHILUS SP - ANVISA Registration 80155020048

Access comprehensive regulatory information for HAEMOPHILUS SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80155020048 and manufactured by programa nacional de controle de qualidade ltda. The registration is held by programa nacional de controle de qualidade ltda with validity until Feb 17, 2035.

This page provides complete technical specifications for this device, regulatory compliance details, 1 companies making the same product including OXOID LIMITED, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.